Literature DB >> 18094436

Analysis of hMLH1 missense mutations in East Asian patients with suspected hereditary nonpolyposis colorectal cancer.

Yimei Fan1, Wei Wang, Ming Zhu, Jiji Zhou, Jingyuan Peng, Lizhi Xu, Zichun Hua, Xiang Gao, Yaping Wang.   

Abstract

PURPOSE: Germ line mutations in the DNA mismatch repair gene hMLH1 are a frequent cause of hereditary nonpolyposis colorectal cancer and about one-third of these are missense mutations. Several missense mutations in hMLH1 have frequently been detected in East Asian patients with suspected hereditary nonpolyposis colorectal cancer, but their pathogenic role has not been extensively assessed. The aim of this study was to perform functional analyses of these variants and their association with gastrointestinal cancer in East Asians. EXPERIMENTAL
DESIGN: Altogether, 10 hMLH1 variants were analyzed by yeast two-hybrid and coimmunoprecipitation assays.
RESULTS: The carboxyl-terminal replacements Q542L, L549P, L574P, and P581L in hMLH1 resulted in complete loss of activity in both yeast two-hybrid and coimmunoprecipitation tests and thus might be considered as pathogenic. The amino-terminal variants S46I, G65D, G67R, and R217C did not affect complex formation with hPMS2 in coimmunoprecipitation, but partly or fully lost their activity in yeast two-hybrid assay, and we suggested that these variants might reduce the efficiency of the heterodimer to go into the nucleus and thus the mismatch repair function might be blocked or reduced. The V384D and the Q701K variant resulted in the interaction of hMLH1 with hPMS2 at reduced efficiency and might raise the gastrointestinal cancer risk of the mutation carriers.
CONCLUSIONS: This work availably evaluated the functional consequences of some missense mutations not previously determined in the hMLH1 gene and might be useful for the clinical diagnosis of hereditary gastrointestinal cancer, especially in East Asians.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094436     DOI: 10.1158/1078-0432.CCR-07-1028

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

Review 1.  Exosomes and cancer: from molecular mechanisms to clinical applications.

Authors:  Ameneh Jafari; Amirhesam Babajani; Meghdad Abdollahpour-Alitappeh; Nayebali Ahmadi; Mostafa Rezaei-Tavirani
Journal:  Med Oncol       Date:  2021-03-20       Impact factor: 3.064

Review 2.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Authors:  Hui-Ling Yap; Wei-Shieng Chieng; Jasmine Rui-Chen Lim; Robert Seng-Cheong Lim; Ross Soo; Jiayi Guo; Soo-Chin Lee
Journal:  Fam Cancer       Date:  2008-08-23       Impact factor: 2.375

5.  The MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males.

Authors:  Wenxian Zhi; Binshuang Xue; Lifeng Wang; Nong Xiao; Qiong He; Yaping Wang; Yimei Fan
Journal:  BMC Gastroenterol       Date:  2011-12-03       Impact factor: 3.067

6.  MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinoma.

Authors:  Chao-Hua Chiu; Hsiang-Ling Ho; Howard Doong; Yi-Chen Yeh; Mei-Yu Chen; Teh-Ying Chou; Chun-Ming Tsai
Journal:  Oncotarget       Date:  2015-04-10

7.  Analysis of human MutS homolog 2 missense mutations in patients with colorectal cancer.

Authors:  Xiaomei Zhang; Senqing Chen; Jun Yu; Yuanying Zhang; Min Lv; Ming Zhu
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

8.  High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer.

Authors:  Seung Eun Lee; Hye Seung Lee; Kyoung-Yeon Kim; Jung-Hoon Park; Hanseong Roh; Ha Young Park; Wan-Seop Kim
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

9.  Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.

Authors:  Fulan Hu; Dandan Li; Yibaina Wang; Xiaoping Yao; Wencui Zhang; Jing Liang; Chunqing Lin; Jiaojiao Ren; Lin Zhu; Zhiwei Wu; Shuying Li; Ye Li; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Yashuang Zhao
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma.

Authors:  Soon Sun Kim; Jung Woo Eun; Ji-Hye Choi; Hyun Goo Woo; Hyo Jung Cho; Hye Ri Ahn; Chul Won Suh; Geum Ok Baek; Sung Won Cho; Jae Youn Cheong
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.